Watch Ticker

MacroGenics, Inc.

Go to MacroGenics, Inc. Website

$1.69

0.05 (2.74%)

Live

Previous Close

$1.64

Day Range

$1.58 - $1.6889

Previous Day Range

$1.531 - $1.665

Market Cap

$99.7 million USD

Day Vol.

337517

Previous Day Vol.

291557

Currency

USD

Primary Exchange

Nasdaq

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Johnson Fistel, Llp - Investigation Alert: MacroGenics, Apellis Pharmaceuticals, Teradata and Maplebear - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information

Johnson Fistel, LLP is investigating potential violations of federal and state laws by certain officers of MacroGenics, Apellis Pharmaceuticals, Teradata, and Maplebear. The investigations are related to alleged false and misleading statements made by the companies.

Related tickers: MGNX, APLS, TDC, CART.

Read Full Article

Researchandmarkets.Com - Immunotoxins Market Trends and Regional Business Opportunities, 2024-2034: Diphtheria Toxin-Based Immunotoxins Lead Revenue, Pseudomonas Exotoxins Show Rapid Growth Potential

The global immunotoxins market is projected to grow at a CAGR of 8.11% from 2024 to 2034, driven by the rising prevalence of malignancies, increased R&D, and the approval of new immunotoxin therapies. Diphtheria toxin-based immunotoxins lead revenue, while Pseudomonas exotoxins show rapid growth potential.

Related tickers: AMGN, ABBV, AZN, BMY, CELGr, NVS, MRK, BNTX, MGNX, IOVA, ZYME.

Read Full Article

Trending Tickers

Please sign in to view